Studying Dynamic Processes of Nano-sized Objects in Liquid using Scanning Transmission Electron Microscopy
February 5th, 2017
13.5K views
This protocol describes the operation of a liquid flow specimen holder for scanning transmission electron microscopy of AuNPs in water, as used for the observation of nanoscale dynamic processes.
Overview
This protocol describes the operation of a liquid flow specimen holder for scanning transmission electron microscopy of AuNPs in water, facilitating the observation of nanoscale dynamic processes.
Key Study Components
Area of Science
- Scanning Transmission Electron Microscopy
- Nanomaterials
- Liquid Phase Imaging
Background
- Liquid phase scanning transmission electron microscopy allows for the observation of nanomaterials in a liquid environment.
- This technique provides nanoscale morphological information about specimens.
- It is particularly useful for studying biological samples in their natural liquid state.
- New users may find the specimen loading and image acquisition challenging.
Purpose of Study
- To observe structures and phenomena of nanomaterials in biological samples.
- To investigate the behavior of nanomaterials in liquid.
- To enhance understanding of nanoscale dynamic processes.
Methods Used
- Cleaning and preparing SiN microchips for specimen loading.
- Applying a gold nanoparticle solution to the microchips.
- Using a liquid flow TEM holder for imaging.
- Conducting leak checks and ensuring proper alignment of microchips.
Main Results
- The protocol successfully demonstrates the preparation and imaging of AuNPs in a liquid environment.
- It outlines the steps for ensuring specimen integrity during the process.
- Results indicate the effectiveness of the liquid flow holder in capturing dynamic processes.
Conclusions
- This method provides valuable insights into the behavior of nanomaterials in liquid.
- It enhances the capability of electron microscopy for studying biological samples.
- Future applications may expand to various fields in materials science.
Frequently Asked Questions
What is the main advantage of liquid phase scanning transmission electron microscopy?
It provides nanoscale morphological information about specimens in a liquid environment.
What materials are used in the specimen holder?
The holder typically uses SiN microchips and requires careful handling to avoid damage.
How is the specimen prepared for imaging?
Specimens are cleaned, coated with gold nanoparticles, and loaded into the holder under controlled conditions.
What challenges do new users face with this method?
New users may struggle with specimen loading and image acquisition processes.
What is the purpose of the liquid flow TEM holder?
It allows for the observation of dynamic processes in nanomaterials while they are immersed in liquid.
How is the integrity of the microchips ensured during the process?
Microchips are inspected for damage and cleaned thoroughly before use.
Executive Industry Relevance
Liquid phase scanning transmission electron microscopy enables direct observation of nanomaterial behavior in physiologically relevant liquid environments, supporting target validation through mechanistic de-risking of nanoparticle-biological interactions. This capability enhances predictive confidence in preclinical models by capturing dynamic processes such as agglomeration, dissolution, and cellular uptake under controlled fluid conditions. The method addresses a critical gap in nanomedicine development by providing nanoscale resolution in hydrated states, reducing reliance on inferential assays and improving go/no-go decisions in early discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing nanomaterial structural changes in liquid, clarifying mechanisms of action and degradation pathways.
- Operational Value: Enables functional target validation through direct observation of nanoparticle interactions with biological components in near-native conditions.
- Predictive Value: Supports portfolio triage by identifying unstable or reactive nanomaterials early, reducing late-stage failure risk due to unforeseen liquid-phase behavior.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream workflows by confirming nanomaterial stability and dispersion in liquid media prior to high-content screening.
- Quantitative Outputs: Enables measurement of particle size, shape, and concentration changes over time, providing reproducible metrics for assay standardization.
- Platform Reuse: Facilitates screening readiness and scalability through standardized microfluidic chip preparation and leak-tight holder assembly, supporting repeated use across compound libraries.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery and preclinical validation by maintaining nanomaterials in liquid environments that mimic physiological conditions, improving relevance of efficacy and toxicity readouts.
- Risk-Adjusted Decisions: Informs advancement criteria by quantifying dynamic processes such as ion-induced dissolution or agglomeration, which directly impact bioavailability and safety profiles.
- Mechanistic De-risking: Focuses on predictive de-risking when primarily mechanistic, clarifying whether observed effects stem from the nanomaterial itself or liquid-phase transformation products.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from Early Discovery through Lead Identification to Preclinical work, supporting hypothesis testing, assay readiness, and translational continuity when nanomaterials are evaluated in liquid environments.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling direct visualization of nanomaterial behavior in liquid, reducing mechanistic ambiguity in target engagement studies.
- Screening: Describes assay readiness through reproducible liquid cell formation and nanoparticle immobilization, ensuring consistent starting conditions for compound evaluation.
- Analytics: Highlights liquid thickness measurement and nanoparticle tracking as key readouts that help teams compare stability across formulations or environmental conditions.
- Translational Research: Connects method to preclinical continuity by maintaining nanomaterials in hydrated states that reflect in vivo exposure, supporting biomarker alignment when dissolution products or agglomerates correlate with biological response.
- Enterprise Reuse:Frames the method as a reusable capability through standardized microfluidic chip preparation, holder assembly, and leak testing protocols, enabling consistent application across projects and teams.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in nanomaterial-biological interactions.
- Operational Value: Standardization, reproducibility, and scalability of liquid cell preparation and imaging workflows.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk by identifying unstable nanomaterials early.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on direct observation of liquid-phase stability and transformation.
Implementation Considerations
- Requires expertise in microfluidic handling, vacuum systems, and electron microscopy to ensure proper specimen holder assembly and leak testing.
- Depends on instrumentation including plasma cleaners, liquid flow TEM holders, and STEM-capable microscopes with environmental holders.
- Necessitates cross-team standardization of chip cleaning, spacer use, and flow rate protocols to ensure reproducibility across sites.
- Involves adaptation considerations when transitioning from water-based to complex biological media, including viscosity effects and potential membrane fouling.
- Includes practical limitations such as beam-induced radiolysis effects on liquid chemistry and the need for vacuum compatibility, which may restrict certain volatile or reactive formulations.
Biopharma FAQs
Why does liquid thickness measurement matter for target validation?
Accurate liquid thickness measurement ensures the specimen is within the optimal range for nanoscale resolution, preventing artifacts from overly thick or absent liquid layers that could misrepresent nanomaterial behavior in biological environments.
How does isolating the independent variable (e.g., ion concentration) fit the discovery pipeline?
By introducing controlled variables like chloride ions, researchers isolate their specific impact on nanomaterial stability, enabling clear attribution of observed changes such as dissolution to defined experimental conditions in early screening.
What quantitative dependent variable measurements enable mechanistic de-risking?
Tracking nanoparticle agglomeration, shape changes, or dissolution rates over time provides quantifiable endpoints that help distinguish intrinsic nanomaterial properties from liquid-phase artifacts, supporting mechanistic de-risking.
Why do replication requirements matter for cross-functional collaboration?
Consistent replication of liquid cell assembly and imaging conditions ensures that nanomaterial behavior observations are reliable across teams, reducing variability in data interpretation between discovery, preclinical, and translational groups.
What statistical analysis capabilities are required before implementation?
Basic statistical comparison of nanoparticle size, count, or distribution across conditions is required to determine significant changes, ensuring that observed dynamics are not due to random variation but reflect true liquid-phase behavior.
